Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine dosing study in ICU patients aged 65 years and older
ACTRN12612000892819Phase 4Recruiting
- Sponsor
- Noorjahan Haneem binti Md Hashim
- Start
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dexmedetomidine in None, sponsored by Noorjahan Haneem binti Md Hashim. Primary endpoint: Optimal dose of dexmedetomidine in elderly ICU patients. Started Nov 2011; status: recruiting.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on ACTRN12612000892819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000892819.